Partner Headlines - MDCO

  1. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga
  2. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga
  3. The Medicines Company Announces First Patient Enrollment In Phase ...

    Benzinga
  4. Midday Gainers From October 28: Buffalo Wild Wings, Integrated ...

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  7. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal ...

    Benzinga
  8. Actavis Expands Antibiotics Presence With Durata Buy

    IBD
  9. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  10. Benzinga's Top Downgrades

    Benzinga
  11. Benzinga's Top Downgrades

    Benzinga
  12. Medicines Co.

    IBD
  13. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  14. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  15. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  16. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  17. Stocks Hitting 52-Week Lows

    Benzinga
  18. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  19. Morning Market Losers

    Benzinga
  20. Benzinga's Top #PreMarket Losers

    Benzinga
  21. Medicines Co. earnings miss

    IBD
  22. Earnings Scheduled For February 19, 2014

    Benzinga
  23. FDA nixes Medicines' drug

    IBD
  24. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  25. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  26. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  27. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  28. Stocks Hitting 52-Week Lows

    Benzinga
  29. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  30. Benzinga's Top #PreMarket Losers

    Benzinga
  31. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  32. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  33. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  34. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  35. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  36. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  37. Medicines acquires Rempex

    IBD
  38. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  39. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  40. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  41. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  42. A Few Stocks Form Bases, But Have Flaws

    IBD
  43. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  44. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  45. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  46. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  47. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  48. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  49. Medicines Co. In Late Stages Of Base Formation

    IBD
  50. Medicines Co. sales topped

    IBD
  51. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  52. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  53. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  54. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  55. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  56. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  57. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  58. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  59. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  60. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  61. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
  62. Medicines Co. Holding On To Its Recent Big Gains

    IBD
  63. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 7,500 Shares

    GuruFocus
  64. Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam ...

    Benzinga
  65. A Peek Into The Market Before The Trading Starts

    Benzinga
  66. The Medicines Company, Alnylam Announce Global Alliance

    Benzinga
  67. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  68. 3D Systems Leads Top 5 Small Caps Despite Stock Slide

    IBD
  69. Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD

    GuruFocus
  70. Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS

    GuruFocus
  71. Medicines (MDCO) President & CFO Glenn Sblendorio sells 125, ...

    GuruFocus
  72. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 2,500 Shares

    GuruFocus
  73. Small Cap Leaders: 3D Systems, IXIA Lead Top 5 Stocks

    IBD
  74. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  75. Medicines (MDCO) President & CFO Glenn Sblendorio sells 25,0 ...

    GuruFocus
  76. 5 Key Stock Moves From JPMorgan Health Care Confab

    IBD
  77. UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, ...

    Benzinga
  78. Eylea Sales Hurt Regeneron

    IBD
  79. Mid-Afternoon Market Update: Markets Fall Further, Isis Pharma ...

    Benzinga
  80. Medtech Stocks Moving As Conference Makes Waves

    IBD
  81. Medtech Stocks Moving As Conference Makes Waves

    IBD
  82. Mid-Day Market Update: Markets Remain Down, The Medicines Company ...

    Benzinga
  83. The Medicines Co. Offers Results of Phase 3 Trial of Cangrelor ...

    Benzinga
  84. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 5,000 Shares

    GuruFocus
  85. Cadence Pharmaceuticals Terminates Option Agreement to Acquire ...

    Benzinga
  86. Medicines Company to Acquire Incline Therapeutics

    Benzinga
  87. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 13,593 Shares

    GuruFocus
  88. Medicines Company Reports Operating Results (10-Q)

    GuruFocus
  89. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 13,600 Shares

    GuruFocus
  90. UPDATE: Jefferies Upgrades The Medicines Company to Buy on Attractive ...

    Benzinga
  91. The Medicines Company Stops Phase 2b Trial of MDCO-2010

    Benzinga
  92. Annovation Biopharma Raises $8M to Develop Novel Anesthetics

    Benzinga
  93. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  94. UPDATE: Bank of America Initiates Neutral, $29 PO on The Medicines ...

    Benzinga
  95. Medicines Company (MDCO) President & CFO Glenn Sblendorio sells ...

    GuruFocus
  96. Medicines Company (MDCO) President & CFO Glenn Sblendorio sells ...

    GuruFocus
  97. The Medicines Co.

    IBD
  98. Health Care Sector Wrap

    FoxBusiness
  99. AOL, The Medicines Company, Other Stocks Hit 52-Week Highs Wednesday

    FoxBusiness
  100. Altera, Symantec Among Stocks Gapping Up Wednesday

    FoxBusiness
Trading Center